Jupiter Neurosciences Inc./$JUNS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jupiter Neurosciences Inc.
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
Ticker
$JUNS
Sector
Primary listing
Employees
5
Headquarters
Website
JUNS Metrics
BasicAdvanced
$10m
-
-$0.26
-
-
Price and volume
Market cap
$10m
52-week high
$3.33
52-week low
$0.17
Average daily volume
11m
Financial strength
Current ratio
0.507
Quick ratio
0.351
Total debt to equity
-173.63
Interest coverage (TTM)
-50.88%
Profitability
Gross margin (TTM)
-5,079.90%
Net profit margin (TTM)
-22,690.83%
Operating margin (TTM)
-23,103.22%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-130.92%
Return on equity (TTM)
-6,529.17%
Valuation
Price to revenue (TTM)
208.609
Price to book
-3.13
Price to tangible book (TTM)
-3.13
Price to free cash flow (TTM)
-1.459
Free cash flow yield (TTM)
-68.55%
Free cash flow per share (TTM)
-0.164
Growth
Earnings per share change (TTM)
138.16%
3-year revenue growth (CAGR)
-44.24%
3-year earnings per share growth (CAGR)
4.60%
JUNS News
AllArticlesVideos
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
Accesswire·2 days ago
Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit
Newsfile Corp·3 weeks ago
Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14
Newsfile Corp·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs